Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Colgate-Palmolive Company (CL) vs iShares MSCI India ETF (INDA) Price & Performance

Colgate-Palmolive CompanyTrade
iShares MSCI India ETFTrade

Price performance (Past 24H)

Key statistics

Colgate-Palmolive Company vs iShares MSCI India ETF — how do they compare? Colgate-Palmolive Company trades at $92.22 (market cap $74.26B), while iShares MSCI India ETF trades at $50.09. The key difference: Colgate-Palmolive Company pays a 2.28% dividend while iShares MSCI India ETF pays none, and Colgate-Palmolive Company is trading nearer its 52-week high, iShares MSCI India ETF nearer its low. Which is the better fit depends on your goals.

CLINDA
Market Cap
$74.26B
Sector
Consumer StaplesBroad Market / Factor
52-Week High
$99.14$55.29
52-Week Low
$74.98$45.42
Enterprise Value
$80.74B
Dividend Yield
2.28%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Colgate-Palmolive Company

Colgate-Palmolive (CL) trades at $93.27, up 0.29% on the day, with a bullish technical signal and consistent earnings beats. The company reported Q2 2026 EPS of $0.99, exceeding estimates, driven by strong margins and organic growth in emerging markets, though North American performance remains weak. Operating cash flow remains robust at $4.2 billion in 2025, supporting shareholder returns.

Outlook is mixed: valuation appears stretched with a P/E of 36.72, but analyst consensus targets $99.10. Risks include competitive pressures in North America and high debt levels. The stock offers a stable dividend, but growth concerns and insider selling warrant caution.

iShares MSCI India ETF

INDA, trading at $50.39 with a 0.54% daily gain, shows a bullish technical outlook supported by moving averages, though RSI levels indicate potential overbought conditions near-term. The ETF tracks India's equity market, the world's fastest-growing large economy, which expanded 7.8% in Q1 2026 (CNBC, June 5, 2026). Recent news highlights foreign capital rotation away from AI-heavy Asian markets, with India facing sector-specific headwinds in pharmaceuticals and IT.

The outlook remains positive given India's robust economic growth, but risks include U.S. tariff uncertainty, Middle East shipping disruptions impacting exports (Reuters, August 4, 2026), and El Niño monsoon concerns. Investor sentiment is mixed amid foreign outflows, yet structural growth opportunities support long-term potential. Key watchpoints are earnings delivery from underlying holdings and macroeconomic stability.

Returns comparison

Trailing returns across standard periods

About Colgate-Palmolive Company

Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.

Read more on CL

About iShares MSCI India ETF

INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.

Read more on INDA